Treatment option of bendamustine in combination with rituximab in elderly and frail patients with aggressive B-non-Hodgkin lymphoma: rational, efficacy, and tolerance-Reference-Cited by-同舟云学术

Treatment option of bendamustine in combination with rituximab in elderly and frail patients with aggressive B-non-Hodgkin lymphoma: rational, efficacy, and tolerance

Published:2012-06-30 Issue:10 Volume:91 Page:1579-1586
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Horn Julia,Kleber Martina,Hieke Stefanie,Schmitt-Gräff Annette,Wäsch Ralph,Engelhardt Monika

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-012-1503-5.pdf

Reference35 articles.

1. Cheson BD, Rummel MJ (2009) Bendamustine: rebirth of an old drug. J Clin Oncol 27(9):1492–1501

2. Rummel M, Gregory S (2011) Bendamustine’s emerging role in the management of lymphoid malignancies. Semin Hematol 48(Suppl 1):24–36

3. Rummel MJ, Al-Batran SE, Kim SZ, Welslau M, Hecker R, Kofahl-Krause D, Josten KM, Durk H, Rost A, Neise M, von Grunhagen U, Chow KU, Hansmann ML, Hoelzer D, Mitrou PS (2005) Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin’s lymphoma. J Clin Oncol 23(15):3383–3389

4. Robinson KS, Williams ME, van der Jagt RH, Cohen P, Herst JA, Tulpule A, Schwartzberg LS, Lemieux B, Cheson BD (2008) Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin’s lymphoma. J Clin Oncol 26(27):4473–4479

5. Pfreundschuh M (2010) How I treat elderly patients with diffuse large B-cell lymphoma. Blood 116(24):5103–5110

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BR vs. R‑miniCHOP in unfit patients with B‑cell non‑Hodgkin lymphoma: A randomized, two‑center, cohort study;Oncology Letters;2023-08-23

2. First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial;HemaSphere;2022-12

3. Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study;Archives of Medical Science;2021-07-16

4. Bendamustine in association with rituximab for first-line treatment of diffuse large B-cell lymphoma in frail patients ineligible for R-CHOP/R-CHOP-like treatments;Anti-Cancer Drugs;2021-03

5. Challenges and Opportunities in the Management of Diffuse Large B-Cell Lymphoma in Older Patients;The Oncologist;2020-12-09